Trademark Attorney / Law Firm
Tara Rahemba – Trademark Portfolio
Tara Rahemba specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 9 of 13 total filings concentrated in this category. The practice also covers Class 44 (Medical Services) along with 4 other Nice Classification classes. Filing activity spans from 2000 to 2019. Currently, 5 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Tara Rahemba's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademark applications has Tara Rahemba filed?
Tara Rahemba has filed 13 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 5 registered, 4 abandoned, 4 cancelled.
What trademark classes does Tara Rahemba specialize in?
Tara Rahemba has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 39 (Transportation & Storage). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Tara Rahemba been filing trademarks?
Tara Rahemba's trademark filing history with the USPTO spans from 2000 to 2019, covering 19 years of trademark practice. During this period, Tara Rahemba has handled 13 trademark applications.
What is Tara Rahemba's trademark registration success rate?
Tara Rahemba has a 38% trademark registration rate, with 5 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.